BioSyent, Inc. (RX.V)
13.00
-0.25
(-1.89%)
CAD |
TSXV |
Jan 14, 15:59
BioSyent Market Cap: 146.41M for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biocure Technology, Inc. | 0.8083M |
| Core One Labs, Inc. | 6.829M |
| Restart Life Sciences Corp. | 4.020M |
| NanoSphere Health Sciences, Inc. | 0.3083M |
| Lobe Sciences Ltd. | 16.17M |
Market Cap Related Metrics
| PE Ratio | 17.26 |
| PS Ratio | 3.529 |
| PEG Ratio | 0.6866 |
| Price to Book Value | 3.669 |
| Price to Free Cash Flow | 18.42 |
| Price | 13.00 |
| Earnings Yield | 5.79% |
| PEGY Ratio | 0.6477 |
| Operating PE Ratio | 13.71 |
| Normalized PE Ratio | 17.26 |